Fortitude Advisory Group L.L.C. Acumen Pharmaceuticals, Inc. Transaction History
Fortitude Advisory Group L.L.C.
- $157 Million
- Q3 2024
A detailed history of Fortitude Advisory Group L.L.C. transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Fortitude Advisory Group L.L.C. holds 13,300 shares of ABOS stock, worth $26,201. This represents 0.02% of its overall portfolio holdings.
Number of Shares
13,300Holding current value
$26,201% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding ABOS
# of Institutions
78Shares Held
41.8MCall Options Held
57.7KPut Options Held
749K-
Ra Capital Management, L.P. Boston, MA14.9MShares$29.4 Million0.52% of portfolio
-
Franklin Resources Inc San Mateo, CA3.55MShares$6.99 Million0.0% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA3.42MShares$6.73 Million4.37% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.3MShares$4.53 Million0.19% of portfolio
-
Black Rock Inc. New York, NY2.16MShares$4.25 Million0.0% of portfolio
About Acumen Pharmaceuticals, Inc.
- Ticker ABOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,503,100
- Market Cap $79.8M
- Description
- Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...